Navigation Links
Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
Date:9/14/2010

Generex's President and Chief Executive Officer.  "This alliance is important as it opens up another key country in South America where diabetes is a highly prevalent condition."

About Generex Biotechnology Corporation

Generex is engaged in the research, development and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  The Company's flagship product, buccal insulin (Generex Oral-lyn™), which has been approved in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Safe Harbor Statement

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to histori
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Alere Inc. Announces Offering of $350 Million of Senior Subordinated Notes
3. RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti
4. Elbit Imaging Announces Share Purchase Agreement With Enter Holdings
5. Regeneron Announces Presentation at the UBS Global Life Sciences Conference
6. Shield Healthcare Announces 10th Annual Caregiver Story Contest
7. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
8. Genoptix Announces Participation at the 2010 UBS Global Life Sciences Conference
9. ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer
10. Sysmex America Announces LabCorp Hematology Automation Agreement
11. K-V Pharmaceutical Company Announces Completion of U.S. Food and Drug Administration Inspection and Approval to Return its First Product to Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... N.J., Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... and reported financial results for the fourth quarter and ... "2014 was a transformative year for PTC. We are ... and developing RNA-targeted therapies in the rare disease space," ... Therapeutics, Inc. "We are proud to bring the first ...
(Date:2/27/2015)...  Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... acquired Bionik Laboratories, Inc., a Toronto ... qualified accredited investors of units consisting of its common ... $6.2 million. Shares of the Company,s common stock will ... the symbol "DWTPD" until FINRA,s approval of the ticker ...
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... , April 29 Abraxis BioScience initially ... the former ICN/Valient Pharmaceutical building in Costa Mesa, ... foot building. The "due diligence report" revealed an array ... occupying the building, and once the building purchase was ...
... April 29 Dendreon Corporation (Nasdaq: ... Food and Drug Administration (FDA) has approved PROVENGE® ... of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) ... an immune response against prostatic acid phosphatase (PAP), ...
Cached Medicine Technology:LCS Constructors, Inc. Completes First Major Phase of Abraxis BioScience Project 2FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 2FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 3FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 4FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 5FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 6FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer 7
(Date:2/28/2015)... (PRWEB) March 01, 2015 Heart diseases ... that 10 percent of urban adult population and 5 ... of heart diseases and 20-30 percent of them require ... heart ailments and coronary vascular diseases (CVD). , A ... a new market research report titled “Indian Coronary Stent ...
(Date:2/28/2015)... 28, 2015 The Classic Denture ... a new special. Throughout all of March patients ... , This service can help overall mouth ... pain. Patients may notice certain symptoms that suggest the ... These symptoms include: , 1.    Pain, clicking, and popping in ...
(Date:2/28/2015)... February 28, 2015 A study out ... new gene therapy procedure for the treatment of a ... patients. Authored by Dr. Robert MacLaren, professor ... in the Lancet Medical Journal on January 16, 2014 ... a rare genetic disorder that mostly affects men and ...
(Date:2/28/2015)... Dr. Perry Patel , a dentist ... announced a special offer for the Zoom!® Chairside ... new and established patients at his Pismo Beach dentist office. To ... smile, Dr. Patel and his staff are offering Zoom! ... the regular price of $450. , Zoom! whitening is ...
(Date:2/28/2015)... York, NY (PRWEB) February 28, 2015 On ... Phishing Kits Make It Easy For Scammers To Steal Your ... anyone can get their hands on a DIY phishing kit, ... But it also touched on another important point about how ... these kits are often implemented, “like compromising legitimate content management ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... In keeping with the American Institute of Ultrasound ... safe and effective use of ultrasound in medicine ... AIUM recognizes the American College of Emergency Physicians ... the qualifications for performing ultrasound in the emergency ...
... , THURSDAY, Dec. 8 (HealthDay News) -- The brains of ... of streets and places of interest over several years, a ... learning can lead to changes in the adult brain, which ... after brain injury, according to the U.K. researchers. The ...
... are reporting they are burned out and dissatisfied with their ... Nursing,s Center for Health Outcomes and Policy Research in a ... 20 to 60 percent of nurses reported symptoms of burnout ... for Quality in Health Care , which collected data from ...
... Copenhagen have explored the active principles of a Danish mushroom ... particularly toxic towards cancer cells. The goal is to synthesise ... in future drug development. Asia has a long ... products. Many substances found in fungi are today registered as ...
... quarter century in Australia, cancer incidence rates have increased while ... the findings of a recent study published early online in ... with any other disease group, cancer has the greatest overall ... cancer and one in five dying from it before the ...
... -- A stressful early pregnancy could lower a woman,s odds ... delivery, a new study suggests. The findings from an ... affected pregnant women in Chile suggest that pregnancy can be ... that often accompany or cause stress, such as poverty, the ...
Cached Medicine News:Health News:AIUM officially recognizes ACEP Emergency Ultrasound Guidelines 2Health News:Taxi Drivers Show How Learning Changes Adult Brain 2Health News:To keep nurses, improve their work environments 2Health News:Danish mushroom inspires cancer researchers 2Health News:Danish mushroom inspires cancer researchers 3Health News:Study sheds light on cancer burden in Australia 2Health News:Stress Early in Pregnancy Linked to Fewer Baby Boys 2
Performa cemented stem....
Porous foundation 480 series....
Porous foundation 440 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
Medicine Products: